順便提一下,可以從雲存儲中下載PDFExamDumps CCDS-O考試題庫的完整版:https://drive.google.com/open?id=1hkd6yXM1qUOLU3t3UFq0IP_5fU_qxyyc
CCDS-O資格認證考試是非常熱門的一項考試,雖然很難通過,但是你只要找准了切入點,考試合格並不是什麼難題。PDFExamDumps就是你最好的選擇。PDFExamDumps命中率高達100%的資料,可以幫你解決CCDS-O考試上的任何難題,只要你認真學習資料上的問題,相信一切難題都可以迎刃而解,你購買了考古題以後還可以得到一年的免費更新服務,一年之內,只要你想更新你擁有的資料,那麼你就可以得到最新版。快點來體驗一下吧。
| Certification Vendor: | ACDIS (Association of Clinical Documentation Integrity Specialists) |
|---|---|
| Exam Name: | ACDIS Certified Clinical Documentation Specialist – Outpatient (CCDS-O) Examination |
| Exam Number: | CCDS-O |
| Real Exam Qty: | 140 questions (120 scored) |
| Passing Score: | 85 out of 120 scored questions |
| Available Languages: | English |
| Exam Format: | Multiple-choice, Computer-based exam |
| Related Certifications: | Certified Clinical Documentation Specialist (CCDS) |
| Recommended Training: | ACDIS Official Certification Resources ACDIS CCDS-O Exam Candidate Handbook (download via official site) |
| Exam Registration: | CCDS-O Certification Information ACDIS Certification Page |
| Sample Questions: | ACDIS CCDS-O Sample Questions |
| Exam Way: | Computer-based testing via Prometric test centers or remote proctoring (ProProctor). |
| Pre Condition: | Must meet education and experience requirements (e.g., RN, MD, DO, or HIM/coding credential such as RHIA, RHIT, CCS, CPC, CRC, COC) plus approximately 1–2 years of outpatient clinical documentation experience using U.S. reimbursement systems. |
| Official Syllabus URL: | https://acdis.org/certification/ccds-o |
如果你還在為了通過ACDIS CCDS-O認證考試苦苦掙扎地奮鬥,此時此刻PDFExamDumps可以給你排憂解難。PDFExamDumps能為你提供品質好的培訓資料來幫助你考試,讓你成為一名優秀的ACDIS CCDS-O的認證會員。如果你已經決定通過ACDIS CCDS-O的認證考試來提升自己,那麼選擇我們的PDFExamDumps是不會有錯的。我們的PDFExamDumps能承諾,一定讓你成功地通過你第一次參加的ACDIS CCDS-O認證考試,拿到ACDIS CCDS-O認證證來提升和改變自己。
| 主題 | 簡介 |
|---|---|
| 主題 1 |
|
| 主題 2 |
|
| 主題 3 |
|
| 主題 4 |
|
問題 #45
Which of the following section(s) of the Official Guidelines for Coding and Reporting are applicable to outpatient settings?
答案:A
解題說明:
In outpatient CDI and coding, the Official ICD-10-CM Guidelines that apply are the universal rules plus the outpatient-specific rules. Section I contains conventions, general coding guidelines, and chapter-specific guidance that govern code assignment in every setting (e.g., code structure, "use additional code," laterality, sequencing instructions, and condition-specific rules). Section IV is specifically written for outpatient services and drives core outpatient behaviors such as selecting the "first-listed" diagnosis based on the main reason for the encounter, reporting additional diagnoses that are evaluated/assessed/treated or impact care, and applying outpatient-only restrictions (for example, diagnoses documented as "rule out," "probable," or "suspected" generally are not coded in outpatient the way they may be for inpatient reporting). ACDIS outpatient CDI education emphasizes teaching providers to document clearly the reason for visit, the assessment/clinical relevance of each condition addressed, and the linkage between conditions and services rendered so Section I and Section IV rules can be applied accurately for compliant reimbursement and reporting.
問題 #46
Provider documentation states: "A 72-year-old patient with an active history of colon cancer, status post bowel resection, receiving chemotherapy. Newly diagnosed lung metastasis. Presents with UTI and elevated creatinine. Labs demonstrate a hemoglobin of 7.9, WBC of 2,500, and platelet count of 20,000." Which of the following is the query opportunity that supports a disease interaction that impacts the risk adjustment?
答案:C
解題說明:
In outpatient risk adjustment, "disease interactions" refer to model coefficients that are triggered when certain clinically related conditions co-exist, reflecting higher expected resource use than either condition alone. In this case, the record already supports active malignancy care (colon cancer on chemotherapy) with newly documented metastasis, and the lab pattern (anemia, leukopenia, and severe thrombocytopenia) strongly suggests pancytopenia. The highest-yield query opportunity is to clarify whether the cytopenias represent chemotherapy-induced pancytopenia (or another specified etiology) because a confirmed, well-specified hematologic complication in the context of active cancer treatment is the type of combination that commonly drives interaction effects in risk models (cancer plus significant systemic complication/manifestation). Options A and B describe clinical context but do not, by themselves, establish an interaction-ready, separately reportable complication. Option C is unrelated to the presented lab-driven severity signal. Querying and documenting chemotherapy-induced pancytopenia supports accurate capture of severity and the interaction impact.
問題 #47
Which of the following is true of the RAF metric?
答案:A
解題說明:
RAF (Risk Adjustment Factor) is a population risk stratification metric used in risk adjustment models to estimate expected healthcare resource utilization for an individual beneficiary relative to an average patient. In outpatient CDI, RAF is driven by a combination of demographic elements (such as age/sex and eligibility/status factors) and-critically-documented, coded conditions that map to risk categories (e.g., HCCs). The intent is not to "predict the provider's reimbursement" for the current year in a direct, visit-by-visit sense; rather, RAF contributes to actuarial projections of expected cost and supports payment benchmarking and budget setting in value-based arrangements (e.g., Medicare Advantage and certain shared savings models). RAF is also not based only on demographics (eliminating option B) and it does not determine reimbursement for each individual office visit (eliminating option D). ACDIS outpatient CDI emphasizes that accurate, specific documentation and coding of active, clinically supported conditions improves the accuracy of RAF, which in turn better aligns projected costs and comparisons across attributed populations.
問題 #48
In February, a patient is diagnosed with prostate cancer, which is classified as HCC 23. In October, the patient is diagnosed with prostate cancer with bone metastases, which is classified as HCC 18. Which of the following is true about the patient's risk score?
答案:D
解題說明:
In the CMS-HCC model, many related conditions are organized into hierarchies so that only the most severe manifestation within a disease family contributes to the RAF. This prevents double counting when multiple codes describe progressive severity of the same underlying condition. Cancer categories are a common example: a diagnosis reflecting metastatic disease represents substantially higher expected resource utilization than a diagnosis of localized/primary malignancy. In this scenario, the February prostate cancer maps to a lower-severity HCC (HCC 23), while the October documentation of prostate cancer with bone metastases maps to a higher-severity HCC (HCC 18). When both are captured within the applicable period, the hierarchy logic retains the higher-weighted metastatic category and suppresses the lower category. The timing of which was coded first does not control the hierarchy outcome, and both HCCs are not counted together when they fall within the same hierarchical grouping. Therefore, the patient's risk score calculation reflects HCC 18 rather than HCC 23.
問題 #49
Clinic documentation states: "Follow-up for post-induction chemotherapy for metastatic uterine cancer." To BEST identify the conditions being monitored and treated, a CDI specialist should
答案:C
解題說明:
When documentation states "metastatic uterine cancer," the most important missing element for complete, accurate outpatient coding is where the cancer has metastasized (the secondary site[s]). In ambulatory CDI, identifying secondary sites best clarifies the full scope of disease being monitored and treated because metastatic disease coding relies on documenting both the primary malignancy and the specific metastatic location(s) (e.g., lung, liver, bone, peritoneum, lymph nodes). This supports correct severity representation, risk capture, treatment intent, and medical necessity for ongoing chemotherapy follow-up. While tumor morphology can be clinically relevant, it is usually established earlier in the diagnostic pathway and does not, by itself, define current metastatic burden. Likewise, reviewing labs or MRI results may provide supportive indicators, but they do not replace provider documentation of the confirmed metastatic sites being managed. A compliant query focused on secondary sites prompts the provider to document the current metastatic disease status (active, responding, progressing) and specific locations, which most directly identifies the conditions under treatment.
問題 #50
......
CCDS-O認證: https://www.pdfexamdumps.com/CCDS-O_valid-braindumps.html
此外,這些PDFExamDumps CCDS-O考試題庫的部分內容現在是免費的:https://drive.google.com/open?id=1hkd6yXM1qUOLU3t3UFq0IP_5fU_qxyyc